Why the question matters
When production is outsourced, a brand owner's customer promise depends on work performed inside another company's walls. Visibility is how the owner learns what is happening there, and it is better understood as a design question about records, responsibilities, and information flow than as a software purchase. This Guide defines the term, explains the mechanics that the retained evidence supports, and gives you checks to apply to your own network, so that you can decide what to settle before you evaluate any technology.
What contract manufacturing visibility means
There is no single standard definition of contract manufacturing visibility, so this Guide uses a working definition: the ability of a brand owner to see, in time to act, the status of work and the quality of records at the facilities that make its product. The FDA's quality agreements guidance gives the clearest vocabulary for the relationship underneath it. In that guidance, owners are manufacturers of finished products or materials, and contract facilities perform one or more manufacturing operations on behalf of an owner. The guidance is written for drugs under current good manufacturing practice, so treat its terms as a precise model of the relationship rather than as a rule for every industry.
The same guidance shows how broad outsourced work can be. Contract facilities perform operations such as formulation, fill and finish, analytical testing, and packaging and labeling. Each outsourced step produces facts the owner may need, including what was run, what was tested, what was released, and what changed, and visibility is the discipline of deciding which of those facts the owner must see and how quickly.
What has to be visible, and to whom
Before choosing any technology, define the facts and the parties. The FDA guidance makes the central point about responsibility: each party engaged in manufacturing a drug is responsible for ensuring CGMP compliance for the activities it performs. Visibility therefore does not transfer accountability to the owner or remove it from the facility. It lets each party see enough to meet its own obligations, which is why the design starts with who is responsible for what.
The guidance also explains why clarity matters. Agreements between owners and contract facilities sometimes do not clearly define each party's roles and manufacturing activities. A visibility design inherits that ambiguity unless the roles are written down first, because a feed or portal cannot resolve a question the agreement leaves open. For a brand owner, the practical categories to settle are:
- Orders and demand: what the owner commits to and what the facility acknowledges.
- Production and materials: status of work, inventory held for the owner, and capacity.
- Quality and engineering: test results, deviations, and approved changes.
- Shipping and exceptions: what has left, what is late, and who owns the response.
How cross-company visibility works
Which mechanism fits is an architecture decision for your environment, and the retained evidence does not rank the options.
What the evidence does support is the pattern that appears when this exchange is not designed. In one ISA article about large project-based manufacturers, a large project manufacturer typically employs between 10 and 15 systems and applications to manage its business processes, and the mix of applications invariably includes massive amounts of spreadsheets. The same article says controllers and data processors export, import, and consolidate data from these systems to create executive reports. Its description of the consequence is specific: under a fragmented application landscape, executives may receive weekly status updates and monthly overviews that are already outdated by the time they arrive. This article was written to introduce a vendor's product category and describes project-based manufacturers, so treat it as an illustration of fragmentation, not as a measurement of contract manufacturing networks.
A hypothetical example shows how the pattern would look across companies. A brand owner receives a weekly spreadsheet from each contract facility, and a planner consolidates them by hand, so the view that reaches a decision maker describes last week. Moving the same facts through a defined, permissioned exchange could make that view more current, but only if both companies agree on which record is authoritative and who updates it. Without that agreement, the new channel would simply carry the same disputes faster.
Where this applies
These are goals to design toward, not results the retained evidence shows any approach will deliver, so state them as targets and test them in a pilot.
The last situation connects to the FDA guidance directly.
Limitations and distinctions
Several distinctions keep the topic honest. First, visibility is not accountability. The FDA states that its guidance describes current thinking, is nonbinding, and that "should" means something is suggested or recommended, not required. Quality agreements document responsibilities, but they do not by themselves create real-time insight, so an owner who relies on the agreement alone still has to design how information actually arrives.
Second, regulated and unregulated contexts differ. The guidance covers commercial manufacturing of drugs and does not cover products such as medical devices and dietary supplements. If you make other products, use it as a model for structuring responsibilities and not as authority for your own obligations.
Third, integration is not the same as buying a new system. The ISA article argues that the solution to a non-integrated mode of operation is to integrate. That principle is reasonable, but the article's own framing is a vendor's category, so the right scope for your network, whether an extension to existing systems, targeted integrations, a portal, or a data platform, depends on your environment and on what your partners can adopt.
Finally, technology does not settle ownership. A portal or feed shows data, but it does not decide which party's record is authoritative, who may see what, or who acts on an exception, and those decisions have to be made by the two companies.
Applying this to your network
Use these checks before choosing a mechanism. They are validation questions, not findings about your environment.
- List the decisions you cannot make today. Name the specific late-breaking facts, such as a delayed run or a held lot, that would change a customer commitment.
- Name the source record for each fact. Identify which system at which company is authoritative, and who is responsible for updating it.
- Write down roles and change control.
- Define permissions. Decide what each facility sees of your data and what you see of theirs, and who approves access.
- Assign exception ownership. For each exception type, state who is notified, who decides, and how fast.
- Start narrow. Test the design with one facility and one decision before extending it to the network, and compare the result with the manual consolidation you would retire.
If you cannot answer the second and third checks, a technology choice is premature. Settling records, roles, and permissions first gives any later portal, integration, or data platform something definite to implement.